Page last updated: 2024-10-16

carbamates and Anxiety

carbamates has been researched along with Anxiety in 68 studies

Anxiety: Feelings or emotions of dread, apprehension, and impending disaster but not disabling as with ANXIETY DISORDERS.

Research Excerpts

ExcerptRelevanceReference
"We showed that JZL184 reduced both the cue- and stress-induced reinstatement of methamphetamine-seeking and anxiety-like behaviors in rats that had self-administered methamphetamine."7.91Inhibition of Monoacylglycerol Lipase Reduces the Reinstatement of Methamphetamine-Seeking and Anxiety-Like Behaviors in Methamphetamine Self-Administered Rats. ( Fukumori, R; Nawata, Y; Yamaguchi, T; Yamamoto, T, 2019)
" In Wistar rats, URB597 effects on alcohol-induced anxiety and on stress-, yohimbine- and cue-induced reinstatement of alcohol seeking were also evaluated."7.74Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat. ( Bilbao, A; Braconi, S; Cannella, N; Ciccocioppo, R; Cippitelli, A; Defonseca, FR; Duranti, A; Piomelli, D; Tontini, A, 2008)
"Our results reveal that experimentally increasing anandamide levels in female prairie voles can increase social contact with both a familiar and novel male via unknown mechanisms that are likely separate from anxiety reduction."4.02Effects of systemic endocannabinoid manipulation on social and exploratory behavior in prairie voles (Microtus ochrogaster). ( Bales, KL; Simmons, TC; Singh, ALK, 2021)
"This study was designed to determine the involvement of the endocannabinoid system in anxiety- and depression-related behaviors in methamphetamine-withdrawal male NMRI mice."4.02URB597 abrogates anxiogenic and depressive behaviors in the methamphetamine-withdrawal mice: Role of the cannabinoid receptor type 1, cannabinoid receptor type 2, and transient receptor potential vanilloid 1 channels. ( Ebrahimi-Ghiri, M; Khakpai, F; Zarrindast, MR, 2021)
"We showed that JZL184 reduced both the cue- and stress-induced reinstatement of methamphetamine-seeking and anxiety-like behaviors in rats that had self-administered methamphetamine."3.91Inhibition of Monoacylglycerol Lipase Reduces the Reinstatement of Methamphetamine-Seeking and Anxiety-Like Behaviors in Methamphetamine Self-Administered Rats. ( Fukumori, R; Nawata, Y; Yamaguchi, T; Yamamoto, T, 2019)
" Exposure to phenobarbital during this period has been associated with deficits in learning and memory, anxiety-like behavior, and social behavior, among other domains."3.83Comparison of the long-term behavioral effects of neonatal exposure to retigabine or phenobarbital in rats. ( Forcelli, PA; Frankel, S; Gutherz, S; Kondratyev, A; Kulick, C; Medvedeva, N, 2016)
" Here, we investigated whether prenatal stress--in the form of gestational exposure to corticosterone supplemented in the maternal drinking water (100 mg/l) during the last week of pregnancy--combined with a pharmacological stimulation of the ECS during adolescence (daily fatty acid amide hydrolase URB597 i."3.78Prenatal stress and peripubertal stimulation of the endocannabinoid system differentially regulate emotional responses and brain metabolism in mice. ( Canese, R; Ceci, C; Laviola, G; Macrì, S, 2012)
"In the present study we explored with a multidisciplinary approach, the role of anandamide (AEA) in the modulation of anxiety behavior at the level of the prefrontal cortex (PFC)."3.74Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex. ( Castiglioni, C; Di Marzo, V; Guidali, C; Maccarrone, M; Marras, E; Parolaro, D; Perletti, G; Petrosino, S; Realini, N; Rubino, T; Viganó, D, 2008)
" In Wistar rats, URB597 effects on alcohol-induced anxiety and on stress-, yohimbine- and cue-induced reinstatement of alcohol seeking were also evaluated."3.74Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat. ( Bilbao, A; Braconi, S; Cannella, N; Ciccocioppo, R; Cippitelli, A; Defonseca, FR; Duranti, A; Piomelli, D; Tontini, A, 2008)
"We hypothesized that restless legs syndrome (RLS), a common neurological sensorimotor disorder of uncomfortable leg sensations that appear at night and interfere with sleep, might be a cause for nighttime agitation in persons with AD."2.94Nighttime Agitation and Restless Legs Syndrome in Persons With Alzheimer's Disease: Study Protocol for a Double-Blind, Placebo-Controlled, Randomized Trial (NightRest). ( Allen, R; Fry, L; Gooneratne, N; Hanlon, A; Kovach, C; Loera, A; Lozano, A; Morrison, J; Rangel, A; Richards, K; Wang, YY, 2020)
"Similar to clinical PTSD, approximately 25-30% of rats that undergo cued fear conditioning exhibit impaired extinction learning."1.56Endocannabinoid modulating drugs improve anxiety but not the expression of conditioned fear in a rodent model of post-traumatic stress disorder. ( Diwan, M; Giacobbe, P; Gidyk, DC; Gouveia, FV; Hamani, C; Lipsman, N; Nobrega, JN; Vimalanathan, A, 2020)
"Treatment with diazepam (1 mg/kg) increased tolerance without affecting avoidance behavior in HAB mice."1.46Enhanced anandamide signaling reduces flight behavior elicited by an approaching robo-beetle. ( Genewsky, A; Heinz, DE; Wotjak, CT, 2017)
"Remarkably, the long-lasting widespread hyperalgesia induced by combining CUS and NGF was effectively reduced by URB597, but not by JZL184."1.42Therapeutic potential of inhibitors of endocannabinoid degradation for the treatment of stress-related hyperalgesia in an animal model of chronic pain. ( Bindila, L; Hoheisel, U; Lerner, R; Lomazzo, E; Lutz, B; Remmers, F; Schwitter, C, 2015)
"Status epilepticus was induced by administration of KA either intraperitoneally (15 mg/kg) or by single intrahippocampal injection (1."1.40Retigabine calms seizure-induced behavior following status epilepticus. ( Ali, SS; Friedman, LK; Naseer, Z; Slomko, AM; Wongvravit, JP, 2014)

Research

Studies (68)

TimeframeStudies, this research(%)All Research%
pre-199028 (41.18)18.7374
1990's0 (0.00)18.2507
2000's12 (17.65)29.6817
2010's22 (32.35)24.3611
2020's6 (8.82)2.80

Authors

AuthorsStudies
da Motta, KP1
Santos, BF1
Domingues, NLC1
Luchese, C1
Wilhelm, EA1
Vimalanathan, A1
Gidyk, DC1
Diwan, M1
Gouveia, FV1
Lipsman, N1
Giacobbe, P1
Nobrega, JN1
Hamani, C1
Ferizovic, H1
Spasojevic, N1
Stefanovic, B1
Jankovic, M1
Dronjak, S1
Richards, K1
Morrison, J1
Wang, YY1
Rangel, A1
Loera, A1
Hanlon, A1
Lozano, A1
Kovach, C1
Gooneratne, N1
Fry, L1
Allen, R1
Simmons, TC1
Singh, ALK1
Bales, KL1
Ebrahimi-Ghiri, M1
Khakpai, F1
Zarrindast, MR1
Aisenberg, N1
Serova, L1
Sabban, EL1
Akirav, I1
Seillier, A2
Giuffrida, A2
Heinz, DE1
Genewsky, A1
Wotjak, CT1
Flannery, LE1
Kerr, DM1
Finn, DP1
Roche, M1
Nawata, Y1
Yamaguchi, T1
Fukumori, R1
Yamamoto, T1
Hartmann, A1
Fassini, A2
Scopinho, A1
Correa, FM1
Guimarães, FS2
Lisboa, SF2
Resstel, LB3
Banji, D1
Banji, OJ1
Ragini, M1
Annamalai, AR1
Slomko, AM1
Naseer, Z1
Ali, SS1
Wongvravit, JP1
Friedman, LK1
Lomazzo, E1
Bindila, L1
Remmers, F1
Lerner, R1
Schwitter, C1
Hoheisel, U1
Lutz, B2
Viana, TG1
Hott, SC1
Aguiar, DC1
Moreira, FA2
Borges, AA1
Nejo, P1
Manduca, A1
Morena, M2
Campolongo, P2
Servadio, M1
Palmery, M1
Trabace, L1
Hill, MN2
Vanderschuren, LJ1
Cuomo, V1
Trezza, V1
Qin, M1
Zeidler, Z1
Moulton, K1
Krych, L1
Xia, Z1
Smith, CB1
Carnevali, L1
Vacondio, F1
Rossi, S1
Macchi, E1
Spadoni, G1
Bedini, A1
Neumann, ID1
Rivara, S1
Mor, M2
Sgoifo, A1
Aliczki, M1
Barna, I2
Till, I1
Baranyi, M1
Sperlagh, B1
Goldberg, SR2
Haller, J3
Frankel, S1
Medvedeva, N1
Gutherz, S1
Kulick, C1
Kondratyev, A1
Forcelli, PA1
Leitl, KD1
Vecchiarelli, HA1
Gray, JM1
Micale, V1
Cristino, L1
Tamburella, A1
Petrosino, S2
Leggio, GM1
Drago, F1
Di Marzo, V2
Barsvari, B1
Gyimesi Pelczer, K1
Yasar, S2
Panlilio, LV1
Goldberg, S1
Roohbakhsh, A1
Keshavarz, S1
Hasanein, P1
Rezvani, ME1
Moghaddam, AH1
Cippitelli, A2
Astarita, G1
Duranti, A3
Caprioli, G1
Ubaldi, M1
Stopponi, S1
Kallupi, M1
Sagratini, G1
Rodrìguez de Fonseca, F1
Piomelli, D4
Ciccocioppo, R2
Zaitone, SA1
El-Wakeil, AF1
Abou-El-Ela, SH1
Macrì, S1
Ceci, C1
Canese, R1
Laviola, G1
Khatri, M1
Rai, SK1
Ranbhor, R1
Kishore, K1
Tiwari, M1
HALPERN, BN1
LEHMANN, A1
GILLHESPY, RO1
CAHN, B1
DARBELLAY, J1
HSU, JJ1
BRAUN, RA1
DOMINO, EF1
LOWINGER, P1
SCHORER, C1
BRUCK, M1
CAUSSE, R1
TOFFOL, DE1
D AMELIO, V1
ANNOVI, G1
RAAB, E1
RICKELS, K1
MOORE, E1
GREENWALD, AS1
SEEHERMAN, R1
GANTT, WH1
BUTTON, JT1
COLE, WV1
CHESROW, EJ1
KAPLITZ, SE1
SABATINI, R1
VETRA, H1
MARQUARDT, GH1
Korsgaard, MP1
Hartz, BP1
Brown, WD1
Ahring, PK1
Strøbaek, D1
Mirza, NR2
Blackburn-Munro, G1
Dalby-Brown, W1
Mikkelsen, JD1
Blackburn-Munro, RE1
Tarzia, G1
Tontini, A2
Compton, TR1
Dasse, O1
Monaghan, EP1
Parrott, JA1
Putman, D1
Naidu, PS1
Varvel, SA1
Ahn, K1
Cravatt, BF1
Martin, BR1
Lichtman, AH1
Kaiser, N1
Monory, K1
Scherma, M1
Medalie, J1
Fratta, W1
Vadivel, SK1
Makriyannis, A1
Mikics, E1
Tanda, G1
Rubino, T1
Realini, N1
Castiglioni, C1
Guidali, C1
Viganó, D1
Marras, E1
Perletti, G1
Maccarrone, M1
Parolaro, D1
Naderi, N1
Haghparast, A1
Saber-Tehrani, A1
Rezaii, N1
Alizadeh, AM1
Khani, A1
Motamedi, F1
Cannella, N1
Braconi, S1
Bilbao, A1
Defonseca, FR1
Spry, WB1
Linford Rees, W1
Guthy, H1
Kissin, B1
Gross, MM1
DiMascio, A2
Gardos, G1
Harmatz, J1
Shader, R1
Shader, RI1
Harmatz, JS1
Lehmann, HE1
Ban, TA1
Bratfos, O1
Lingjaerde, O1
Salvesen, C1
Cremoncini, C1
Liuzzi, A1
Perez de Francisco, C1
Meshel, E1
Denber, HC1
Solaro, F1
Corletto, F1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease[NCT03082755]Phase 4156 participants (Anticipated)Interventional2017-07-01Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

3 reviews available for carbamates and Anxiety

ArticleYear
Retigabine: chemical synthesis to clinical application.
    CNS drug reviews, 2005,Spring, Volume: 11, Issue:1

    Topics: Animals; Anticonvulsants; Anxiety; Carbamates; Dose-Response Relationship, Drug; Epilepsy; Humans; K

2005
Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597).
    CNS drug reviews, 2006,Spring, Volume: 12, Issue:1

    Topics: Amidohydrolases; Analgesics; Animals; Anxiety; Benzamides; Brain; Cannabinoids; Carbamates; Depressi

2006
Pharmacotherapy of tension and anxiety.
    Current psychiatric therapies, 1972, Volume: 12

    Topics: Anxiety; Automobile Driving; Carbamates; Cerebral Cortex; Clinical Trials as Topic; Depression; Dibe

1972

Trials

7 trials available for carbamates and Anxiety

ArticleYear
Nighttime Agitation and Restless Legs Syndrome in Persons With Alzheimer's Disease: Study Protocol for a Double-Blind, Placebo-Controlled, Randomized Trial (NightRest).
    Research in gerontological nursing, 2020, 11-01, Volume: 13, Issue:6

    Topics: Aged; Alzheimer Disease; Anxiety; Carbamates; Double-Blind Method; Female; gamma-Aminobutyric Acid;

2020
Tybamate: an examination of its actions in "high" and "low" anxious normals.
    Diseases of the nervous system, 1969, Volume: 30, Issue:11

    Topics: Adult; Anxiety; Blood Pressure; Carbamates; Chlordiazepoxide; Clinical Trials as Topic; Cognition; E

1969
Single versus repeated dosage of the minor tranquilizer chlordiazepoxide (Librium).
    The American journal of psychiatry, 1972, Volume: 128, Issue:12

    Topics: Adult; Anxiety; Blood Pressure; Carbamates; Chlordiazepoxide; Clinical Trials as Topic; Evaluation S

1972
Pharmacotherapy of tension and anxiety.
    Current psychiatric therapies, 1972, Volume: 12

    Topics: Anxiety; Automobile Driving; Carbamates; Cerebral Cortex; Clinical Trials as Topic; Depression; Dibe

1972
Symptomatic relief of neurotic symptoms with tybamate: a doube-blind, placebo-controlled study.
    Acta psychiatrica Scandinavica, 1967, Volume: 43, Issue:3

    Topics: Adult; Aged; Anxiety; Carbamates; Clinical Trials as Topic; Depression; Female; Humans; Hysteria; Ma

1967
Serax and solacen.
    The Medical letter on drugs and therapeutics, 1965, Nov-05, Volume: 7, Issue:23

    Topics: Aged; Antidepressive Agents; Anxiety; Carbamates; Clinical Trials as Topic; Humans; Hyperventilation

1965
Double-blind study of tybamate in psychotic patients.
    Diseases of the nervous system, 1967, Volume: 28, Issue:5

    Topics: Adult; Aged; Aggression; Anxiety; Carbamates; Clinical Trials as Topic; Depression; Female; Humans;

1967

Other Studies

59 other studies available for carbamates and Anxiety

ArticleYear
Target enzymes in oxaliplatin-induced peripheral neuropathy in Swiss mice: A new acetylcholinesterase inhibitor as therapeutic strategy.
    Chemico-biological interactions, 2022, Jan-25, Volume: 352

    Topics: Adenosine Triphosphatases; Analgesics; Animals; Anxiety; Benzoates; Carbamates; Cerebral Cortex; Cho

2022
Endocannabinoid modulating drugs improve anxiety but not the expression of conditioned fear in a rodent model of post-traumatic stress disorder.
    Neuropharmacology, 2020, Volume: 166

    Topics: Animals; Anxiety; Benzamides; Benzoxazines; Carbamates; Conditioning, Psychological; Disease Models,

2020
The fatty acid amide hydrolase inhibitor URB597 modulates splenic catecholamines in chronically stressed female and male rats.
    International immunopharmacology, 2020, Volume: 85

    Topics: Amidohydrolases; Animals; Anti-Anxiety Agents; Anxiety; Benzamides; Carbamates; Catechol O-Methyltra

2020
Effects of systemic endocannabinoid manipulation on social and exploratory behavior in prairie voles (Microtus ochrogaster).
    Psychopharmacology, 2021, Volume: 238, Issue:1

    Topics: Animals; Anxiety; Arachidonic Acids; Arvicolinae; Behavior, Animal; Benzamides; Carbamates; Endocann

2021
URB597 abrogates anxiogenic and depressive behaviors in the methamphetamine-withdrawal mice: Role of the cannabinoid receptor type 1, cannabinoid receptor type 2, and transient receptor potential vanilloid 1 channels.
    Journal of psychopharmacology (Oxford, England), 2021, Volume: 35, Issue:7

    Topics: Amidohydrolases; Animals; Anxiety; Behavior, Animal; Benzamides; Cannabinoid Receptor Antagonists; C

2021
The effects of enhancing endocannabinoid signaling and blocking corticotrophin releasing factor receptor in the amygdala and hippocampus on the consolidation of a stressful event.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2017, Volume: 27, Issue:9

    Topics: Amidohydrolases; Animals; Anxiety; Basolateral Nuclear Complex; Benzamides; CA1 Region, Hippocampal;

2017
Anxiety does not contribute to social withdrawal in the subchronic phencyclidine rat model of schizophrenia.
    Behavioural pharmacology, 2017, Volume: 28, Issue:7

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Anxiety Disorders; Behavior, Animal; Cannabinoids; Carbamates

2017
Enhanced anandamide signaling reduces flight behavior elicited by an approaching robo-beetle.
    Neuropharmacology, 2017, Volume: 126

    Topics: Amidohydrolases; Animals; Anti-Anxiety Agents; Anxiety; Arachidonic Acids; Avoidance Learning; Behav

2017
FAAH inhibition attenuates TLR3-mediated hyperthermia, nociceptive- and anxiety-like behaviour in female rats.
    Behavioural brain research, 2018, 11-01, Volume: 353

    Topics: Amidohydrolases; Animals; Anxiety; Benzamides; Carbamates; Central Nervous System Agents; Enzyme Inh

2018
Inhibition of Monoacylglycerol Lipase Reduces the Reinstatement of Methamphetamine-Seeking and Anxiety-Like Behaviors in Methamphetamine Self-Administered Rats.
    The international journal of neuropsychopharmacology, 2019, 02-01, Volume: 22, Issue:2

    Topics: Amidohydrolases; Amphetamine-Related Disorders; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Add

2019
Role of the endocannabinoid system in the dorsal hippocampus in the cardiovascular changes and delayed anxiety-like effect induced by acute restraint stress in rats.
    Journal of psychopharmacology (Oxford, England), 2019, Volume: 33, Issue:5

    Topics: Amidohydrolases; Animals; Anxiety; Arachidonic Acids; Arterial Pressure; Behavior, Animal; Benzamide

2019
Carbosulfan exposure during embryonic period can cause developmental disability in rats.
    Environmental toxicology and pharmacology, 2014, Volume: 38, Issue:1

    Topics: Acetylcholinesterase; Animals; Animals, Newborn; Anxiety; Behavior, Animal; Brain; Carbamates; Embry

2014
Retigabine calms seizure-induced behavior following status epilepticus.
    Epilepsy & behavior : E&B, 2014, Volume: 37

    Topics: Animals; Anticonvulsants; Anxiety; Behavior, Animal; Carbamates; Convulsants; Hippocampus; Hyperkine

2014
Therapeutic potential of inhibitors of endocannabinoid degradation for the treatment of stress-related hyperalgesia in an animal model of chronic pain.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2015, Volume: 40, Issue:2

    Topics: Amidohydrolases; Analgesics, Non-Narcotic; Animals; Anxiety; Benzamides; Benzodioxoles; Brain; Carba

2015
Anti-aversive role of the endocannabinoid system in the periaqueductal gray stimulation model of panic attacks in rats.
    Psychopharmacology, 2015, Volume: 232, Issue:9

    Topics: Amidohydrolases; Animals; Anxiety; Arachidonic Acids; Behavior, Animal; Benzamides; Carbamates; Dise

2015
Cannabinoid CB1 receptors in the dorsal hippocampus and prelimbic medial prefrontal cortex modulate anxiety-like behavior in rats: additional evidence.
    Progress in neuro-psychopharmacology & biological psychiatry, 2015, Jun-03, Volume: 59

    Topics: Animals; Anxiety; Arachidonic Acids; Benzamides; Carbamates; Disease Models, Animal; Drinking; Drink

2015
Distinct roles of the endocannabinoids anandamide and 2-arachidonoylglycerol in social behavior and emotionality at different developmental ages in rats.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2015, Volume: 25, Issue:8

    Topics: Aging; Animals; Anxiety; Arachidonic Acids; Brain; Cannabinoid Receptor Modulators; Carbamates; Endo

2015
Endocannabinoid-mediated improvement on a test of aversive memory in a mouse model of fragile X syndrome.
    Behavioural brain research, 2015, Sep-15, Volume: 291

    Topics: Amidohydrolases; Animals; Anxiety; Arachidonic Acids; Avoidance Learning; Benzamides; Cannabinoid Re

2015
Cardioprotective effects of fatty acid amide hydrolase inhibitor URB694, in a rodent model of trait anxiety.
    Scientific reports, 2015, Dec-14, Volume: 5

    Topics: Amidohydrolases; Animals; Anti-Anxiety Agents; Anxiety; Arrhythmias, Cardiac; Behavior, Animal; Biph

2015
The effects anandamide signaling in the prelimbic cortex and basolateral amygdala on coping with environmental stimuli in rats.
    Psychopharmacology, 2016, Volume: 233, Issue:10

    Topics: Adaptation, Psychological; Animals; Anti-Anxiety Agents; Anxiety; Arachidonic Acids; Basolateral Nuc

2016
Comparison of the long-term behavioral effects of neonatal exposure to retigabine or phenobarbital in rats.
    Epilepsy & behavior : E&B, 2016, Volume: 57, Issue:Pt A

    Topics: Animals; Animals, Newborn; Anticonvulsants; Anxiety; Behavior, Animal; Carbamates; Cognition; Dose-R

2016
Emotional arousal state influences the ability of amygdalar endocannabinoid signaling to modulate anxiety.
    Neuropharmacology, 2016, Volume: 111

    Topics: Animals; Anxiety; Arachidonic Acids; Arousal; Basolateral Nuclear Complex; Benzamides; Cannabinoid R

2016
Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2009, Volume: 34, Issue:3

    Topics: Amidohydrolases; Anilides; Animals; Anti-Anxiety Agents; Anxiety; Arachidonic Acids; Benzamides; Bra

2009
Interactions between environmental aversiveness and the anxiolytic effects of enhanced cannabinoid signaling by FAAH inhibition in rats.
    Psychopharmacology, 2009, Volume: 204, Issue:4

    Topics: Amidohydrolases; Animals; Anti-Anxiety Agents; Anxiety; Benzamides; Carbamates; Chlordiazepoxide; Di

2009
Role of endocannabinoid system in the ventral hippocampus of rats in the modulation of anxiety-like behaviours.
    Basic & clinical pharmacology & toxicology, 2009, Volume: 105, Issue:5

    Topics: Amidohydrolases; Animals; Anxiety; Baclofen; Behavior, Animal; Benzamides; Bicuculline; Cannabinoid

2009
Inhibition of fatty acid amide hydrolase modulates anxiety-like behavior in PCP-treated rats.
    Pharmacology, biochemistry, and behavior, 2011, Volume: 98, Issue:4

    Topics: Amidohydrolases; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Benzamides; Carbamates; En

2011
Endocannabinoid regulation of acute and protracted nicotine withdrawal: effect of FAAH inhibition.
    PloS one, 2011, Volume: 6, Issue:11

    Topics: Acute Disease; Amidohydrolases; Animals; Anxiety; Arachidonic Acids; Benzamides; Brain; Cannabinoid

2011
Inhibition of fatty acid amide hydrolase by URB597 attenuates the anxiolytic-like effect of acetaminophen in the mouse elevated plus-maze test.
    Behavioural pharmacology, 2012, Volume: 23, Issue:4

    Topics: Acetaminophen; Amidohydrolases; Animals; Anti-Anxiety Agents; Anxiety; Arachidonic Acids; Benzamides

2012
Prenatal stress and peripubertal stimulation of the endocannabinoid system differentially regulate emotional responses and brain metabolism in mice.
    PloS one, 2012, Volume: 7, Issue:7

    Topics: Anhedonia; Animals; Anxiety; Benzamides; Body Weight; Brain; Carbamates; Corticosterone; Drinking; E

2012
Synthesis and pharmacological evaluation of [(4-arylpiperazin-1-yl)-alkyl]-carbamic acid ethyl ester derivatives as potential anxiolytic agents.
    Archives of pharmacal research, 2012, Volume: 35, Issue:7

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Carbamates; Cerebral Cortex; Computer-Aided

2012
[Experimental bases of the therapeutic action of a new sedative and anti-anxious preparation: 3-methyl-1-pentyne-3-o1 carbamate].
    La Presse medicale, 1957, Apr-03, Volume: 65, Issue:27

    Topics: Anxiety; Carbamates; Humans; Hypnotics and Sedatives; Tranquilizing Agents

1957
Methylpentynol carbamate in the management of insomnia and parkinsonism.
    The British journal of clinical practice, 1958, Volume: 12, Issue:3

    Topics: Anxiety; Carbamates; Humans; Parkinson Disease; Parkinsonian Disorders; Sleep Initiation and Mainten

1958
Effect of hydroxyphenamate in the treatment of mild and moderate anxiety states. (A double blind study with crossover pattern).
    Diseases of the nervous system, 1961, Volume: 22(9)Suppl

    Topics: Anxiety; Butylene Glycols; Carbamates; Double-Blind Method; Tranquilizing Agents

1961
[THE ORTHONEUROTIC EMYLCAMATE IN DAILY PRACTICE].
    Bruxelles medical, 1963, Oct-06, Volume: 43

    Topics: Alcoholism; Anxiety; Anxiety Disorders; Automobiles; Carbamates; Cats; Depression; Geriatrics; Mice;

1963
CLINICAL EVALUATION OF HYDROXYPHENAMATE IN PSYCHOTIC PATIENTS.
    Diseases of the nervous system, 1963, Volume: 24

    Topics: Anxiety; Brain; Brain Damage, Chronic; Butylene Glycols; Carbamates; Humans; Mental Disorders; Psych

1963
[VALUE OF 1-CYCLOHEXYLPROPYL CARBAMATE IN NEURO-PSYCHIATRY].
    Lyon medical, 1963, Dec-29, Volume: 210

    Topics: Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Anxiety Disorders; Carbamates; Humans; Neurolog

1963
[TREATMENT WITH MEBUTAMATE (AN ANTIHYPERTENSIVE WITH CENTRAL ACTION) OF MENTAL PATIENTS WITH HYPERTENSIVE MANIFESTATIONS].
    Gazzetta medica italiana, 1963, Volume: 122

    Topics: Alcoholism; Antihypertensive Agents; Anxiety; Bipolar Disorder; Carbamates; Dementia; Epilepsy; Huma

1963
A DOUBLE-BLIND EVALUATION OF TYBAMATE IN ANXIOUS NEUROTIC MEDICAL CLINIC PATIENTS.
    The American journal of psychiatry, 1964, Volume: 120

    Topics: Anxiety; Anxiety Disorders; Biomedical Research; Black People; Carbamates; Double-Blind Method; Huma

1964
RELIEF OF TENSION IN DENTAL PATIENTS: A CONTROLLED STUDY WITH HYDROXYPHENAMATE.
    Journal of the American Dental Association (1939), 1964, Volume: 68

    Topics: Anxiety; Anxiety Disorders; Biomedical Research; Butylene Glycols; Carbamates; Dentistry; Pharmacolo

1964
EVALUATION OF TYBAMATE IN THE CLINICAL MANAGEMENT OF ANXIETY.
    Delaware medical journal, 1964, Volume: 36

    Topics: Anxiety; Biomedical Research; Carbamates; Placebos; Toxicology; Tranquilizing Agents

1964
THE FUTURE OF TRANQUILIZER RESEARCH AND THE THERAPY OF ANXIETY. EXPERIMENTAL STUDIES IN ANIMALS OF THE EFFECTS OF DRUGS ON CARDIAC STRESS SYMPTOMS.
    Journal of neuropsychiatry, 1964, Volume: 5

    Topics: Animals; Anxiety; Blood Pressure; Carbamates; Conditioning, Classical; Dogs; Electrocardiography; He

1964
TREATMENT OF EMOTIONAL DISTURBANCES IN CLINIC PATIENTS.
    The Journal of the American Osteopathic Association, 1965, Volume: 64

    Topics: Adolescent; Affective Symptoms; Anxiety; Anxiety Disorders; Biomedical Research; Carbamates; Drug Th

1965
A NEW PSYCHOTHERAPEUTIC AGENT EFFECTIVE IN THE MANAGEMENT OF GERIATRIC ANXIETY, DEPRESSION AND BEHAVIORAL REACTIONS.
    Journal of the American Geriatrics Society, 1965, Volume: 13

    Topics: Anxiety; Anxiety Disorders; Biomedical Research; Brain; Brain Damage, Chronic; Carbamates; Depressio

1965
Anxiolytic effects of Maxipost (BMS-204352) and retigabine via activation of neuronal Kv7 channels.
    The Journal of pharmacology and experimental therapeutics, 2005, Volume: 314, Issue:1

    Topics: Algorithms; Animals; Anti-Anxiety Agents; Anxiety; Ataxia; Behavior, Animal; Carbamates; Cell Line;

2005
Evaluation of fatty acid amide hydrolase inhibition in murine models of emotionality.
    Psychopharmacology, 2007, Volume: 192, Issue:1

    Topics: Amidohydrolases; Animals; Anxiety; Arachidonic Acids; Behavior, Animal; Benzamides; Cannabinoid Rece

2007
Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors.
    Neuropharmacology, 2008, Volume: 54, Issue:1

    Topics: Amidohydrolases; Analysis of Variance; Animals; Anxiety; Arachidonic Acids; Behavior, Animal; Benzam

2008
The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition.
    Neuropharmacology, 2008, Volume: 54, Issue:1

    Topics: Amidohydrolases; Analgesics; Analysis of Variance; Animals; Anxiety; Arachidonic Acids; Avoidance Le

2008
Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex.
    Cerebral cortex (New York, N.Y. : 1991), 2008, Volume: 18, Issue:6

    Topics: Animals; Anxiety; Arachidonic Acids; Benzamides; Cannabinoid Receptor Modulators; Carbamates; Dose-R

2008
Interaction between cannabinoid compounds and diazepam on anxiety-like behaviour of mice.
    Pharmacology, biochemistry, and behavior, 2008, Volume: 89, Issue:1

    Topics: Amidohydrolases; Animals; Anxiety; Arachidonic Acids; Behavior, Animal; Benzamides; Benzoxazines; Ca

2008
Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat.
    Psychopharmacology, 2008, Volume: 198, Issue:4

    Topics: Adrenergic alpha-Antagonists; Alcohol Drinking; Alcoholism; Amidohydrolases; Animals; Anxiety; Arach

2008
Tybamate.
    British medical journal, 1967, Jan-28, Volume: 1, Issue:5534

    Topics: Anxiety; Carbamates; Depression; Humans; Tranquilizing Agents

1967
Tybamate: a new tranquillizer.
    The British journal of clinical practice, 1967, Volume: 21, Issue:4

    Topics: Adolescent; Adult; Anxiety; Carbamates; Depression; Female; Humans; Male; Middle Aged; Tranquilizing

1967
The treatment of anxiety states by drugs and other means.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1979, Oct-27, Volume: 56, Issue:18

    Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Anxiety; Barbit

1979
[The medicinal treatment of anxiety in alcoholism in the withdrawal stage (author's transl)].
    MMW, Munchener medizinische Wochenschrift, 1975, Aug-29, Volume: 117, Issue:35

    Topics: Adult; Alcoholism; Anti-Anxiety Agents; Anxiety; Benzodiazepines; Carbamates; Chemical Phenomena; Ch

1975
Drug therapy in alcoholism.
    Current psychiatric therapies, 1970, Volume: 10

    Topics: Adult; Alcoholic Intoxication; Alcoholism; Antidepressive Agents; Anxiety; Carbamates; Chlordiazepox

1970
[Tybamate, recently synthetized anxiolytic agent, in the treatment of emotional and neurovegetative symptoms of hyperthyroidism. Clinico-statistical study].
    Minerva medica, 1972, Jan-24, Volume: 63, Issue:5

    Topics: Adolescent; Adult; Affective Symptoms; Aged; Animals; Anxiety; Autonomic Nervous System; Carbamates;

1972
[Psychopharmacological treatment of anxiety].
    La Prensa medica mexicana, 1971, Volume: 36, Issue:9

    Topics: Adult; Amitriptyline; Anxiety; Benzazepines; Carbamates; Chlordiazepoxide; Diazepam; Dibenzazepines;

1971
[Tybamate in the practice at geriatric outpatient clinics].
    Giornale di gerontologia, 1968, Volume: 16, Issue:1

    Topics: Aged; Anxiety; Brain Damage, Chronic; Carbamates; Depression; Female; Humans; Male; Middle Aged; Out

1968
Evaluation of a new minor tranquilizer: tybamate (Solacen).
    JAMA, 1965, Dec-06, Volume: 194, Issue:10

    Topics: Anxiety; Carbamates; Humans; Tranquilizing Agents

1965